• ALDOB K87 Lactylation Orchestrates Mitochondrial Fission in

  2026-05-12

  This study unveils ALDOB K87 lactylation as a driver of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH), linking metabolic flux to pathological vascular remodeling. The findings highlight a lactate–ALDOB–DRP1 axis and suggest new targets for PH intervention.

• TaqI Restriction Endonuclease: Rapid DNA Digestion Protocols

  2026-05-12

  TaqI Restriction Endonuclease enables fast, sequence-specific digestion of plasmid, PCR, or genomic DNA, reducing workflow time for researchers who require efficient DNA cleavage. It is suitable for molecular biology applications where rapid, reliable restriction is needed, but is not intended for diagnostic or medical use.

• miR-18a Drives Glioblastoma via ALOXE3 Ferroptosis Suppressi

  2026-05-11

  This study uncovers a mechanistic link between miR-18a and glioblastoma progression, demonstrating that miR-18a enhances tumor growth by down-regulating ALOXE3, thereby reducing ferroptosis and increasing cell migration. These findings highlight the miR-18a/ALOXE3 axis as a promising therapeutic target and suggest new directions for signal transduction modulation in cancer biology.

• Platanoside Mitigates Ferroptosis in Acute Lung Injury via N

  2026-05-11

  This study uncovers a novel mechanism by which platanoside, a flavonoid glycoside, alleviates ferroptosis-driven acute lung injury (ALI) through autophagy-dependent Keap1 degradation, thereby activating the Nrf2/GPX4 antioxidant axis. The findings highlight an integrative regulatory pathway with potential translational implications for oxidative stress-related tissue pathology.

• Qushi Huoxue Ointment Modulates Autophagy and Ferroptosis in

  2026-05-10

  Liu et al. present compelling evidence that Qushi Huoxue ointment (QSHXO) alleviates metabolic associated steatotic liver disease (MASLD) in a murine model by activating autophagy and inhibiting ferroptosis. These mechanistic insights clarify QSHXO’s therapeutic potential and highlight the broader relevance of redox and cell-death modulation for MASLD intervention strategies.

• LY294002: Potent PI3K/Akt/mTOR Pathway Inhibitor for Cancer

  2026-05-09

  LY294002 is a well-characterized, reversible inhibitor of class I PI3Ks, used widely in cancer and autophagy research. It selectively blocks PI3K/Akt/mTOR signaling, modulates apoptosis and autophagy, and inhibits BET bromodomains at micromolar concentrations. APExBIO supplies LY294002 (A8250) as a solid, highly pure reagent for in vitro and in vivo studies.

• Mitochondrial Calcium and Ferroptosis: Mechanistic Insights

  2026-05-08

  This study establishes a direct mechanistic link between mitochondrial calcium influx, mediated by the mitochondrial calcium uniporter (MCU), and the repression of ferroptotic cell death via GPX4 acetylation. The findings have broad significance for tumor cell metabolism research and suggest new avenues for targeting metabolic vulnerabilities in cancer.

• Alternariol in Mycotoxin Research: Applied Workflows & Tips

  2026-05-08

  Alternariol (AOH) is a pivotal tool for understanding fungal toxin mechanisms, especially hepatotoxicity and apoptosis. This article translates the latest omics-based findings into step-by-step experimental workflows, protocol optimizations, and troubleshooting strategies—empowering mycotoxin researchers to generate robust, reproducible insights.

• Cy5 TSA Fluorescence System Kit: Precision Signal Amplificat

  2026-05-07

  Discover how the Cy5 TSA Fluorescence System Kit leverages horseradish peroxidase catalyzed tyramide deposition for superior signal amplification in immunohistochemistry and in situ hybridization, with unique insights for inflammatory disease research.

• Microglial BDNF Regulates Antidepressant Effects via mPFC-NA

  2026-05-07

  This article analyzes how microglial-derived BDNF mediates the rapid antidepressant-like effects of arketamine through specific cortico-accumbal circuitry. The study reveals that BDNF from microglia is crucial for activating medial prefrontal cortex neurons projecting to the nucleus accumbens, offering new mechanistic insight and potential targets for depression research.

• EZ Cap™ Human PTEN mRNA: Optimizing Tumor Suppressor Restora

  2026-05-06

  EZ Cap™ Human PTEN mRNA unlocks robust, scalable restoration of PTEN function using advanced Cap 1 and poly(A) tail modifications. This guide details experimental workflows, troubleshooting, and next-gen delivery applications—including HA-LNP-based immunotherapy—empowering cancer and gene therapy research.

• Minocycline HCl: Optimized Protocols for Neuroinflammation R

  2026-05-06

  Minocycline HCl stands out as a dual-action agent, merging potent antimicrobial efficacy with advanced anti-inflammatory and neuroprotective capabilities for translational research. This article provides a workflow-driven guide for leveraging minocycline hydrochloride in scalable extracellular vesicle (EV) production, neuroinflammation modeling, and troubleshooting, synthesizing the latest evidence and hands-on protocol enhancements.

• D-Luciferin: Firefly Luciferase Substrate for Tumor Burden a

  2026-05-05

  D-Luciferin enables ultrasensitive, real-time imaging of tumor burden and soluble immunotherapy biomarkers, making it indispensable for both in vitro and in vivo studies. This article translates the latest research advances into actionable protocols and troubleshooting strategies for maximizing the performance of D-Luciferin-based assays.

• A-1331852: Selective BCL-XL Inhibitor for Advanced Apoptosis

  2026-05-05

  A-1331852 is a potent BCL-XL inhibitor used in apoptosis assays and cancer research. It displays high selectivity and nanomolar potency, offering a reliable tool for dissecting BCL-2 family protein inhibition and advancing senolytic strategies.

• Tacrine Hydrochloride Hydrate in Alzheimer's Disease Researc

  2026-05-04

  Tacrine hydrochloride hydrate (tetrahydroaminacrine) remains the gold-standard tool for dissecting cholinergic signaling and neuroprotection in Alzheimer's disease models. This article delivers actionable workflows, advanced troubleshooting, and evidence-driven protocol optimization to maximize data quality and reproducibility in neurodegenerative disease research.

15104 records 1/1007 page Next 12345 下5页 Last page